Browse > Article
http://dx.doi.org/10.3339/ckd.22.029

BK polyomavirus-associated nephropathy  

Ahn, Yo Han (Department of Pediatrics, Seoul National University College of Medicine)
Kang, Hee Gyung (Department of Pediatrics, Seoul National University College of Medicine)
Publication Information
Childhood Kidney Diseases / v.26, no.1, 2022 , pp. 11-17 More about this Journal
Abstract
BK polyomavirus (BKPyV) is a ubiquitous virus residing in the kidney tubules and is clinically significant only in immunocompromised patients. In clinical practice, BKPyV is a causative pathogen of BKPyV-associated nephropathy (BKVAN) in kidney allograft recipients or hemorrhagic cystitis of hematopoietic stem cell transplant recipients. Currently, there is no effective treatment for BKVAN; therefore, careful monitoring and prudent modification of immunosuppression are necessary to prevent BKVAN. In this article, the epidemiology, pathophysiology, and current management strategies for BKVAN are reviewed.
Keywords
BK virus; Immunosuppression therapy; Kidney transplantation;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Myint TM, Chong C, Wyld M, Nankivell B, Kable K, Wong G. Polyoma BK virus in kidney transplant recipients: screening, monitoring, and management. Transplantation 2022;106:e76-89.   DOI
2 Hirsch HH, Randhawa PS; AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. ClinTransplant 2019;33:e13528.
3 Vanichanan J, Udomkarnjananun S, Avihingsanon Y, Jutivorakool K. Common viral infections in kidney transplant recipients. Kidney Res Clin Pract 2018;37:323-37.   DOI
4 Kwon Y, Kim JY, Lee Y, Cho H. Clinical manifestations of BK virus infection in pediatric kidney transplant patients. Korean J Pediatr 2019;62:422-7.   DOI
5 Schold JD, Rehman S, Kayle LK, Magliocca J, Srinivas TR, Meier-Kriesche HU. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl Int 2009;22:626-34.   DOI
6 Ryu TH, Kim Hy, Oh JS, Kim JK. Combination therapy of low-dose cidofovir and leflunomide in a kidney transplant recipient with BK virus nephropathy: a case report. Korean J Transplant 2021;35(Supple 1):S61.   DOI
7 Mallat SG, Tanios BY, Itani HS, Lotfi T, McMullan C, Gabardi S, et al. CMV and BKPyV infections in renal transplant recipients receiving an mTOR inhibitor-based regimen versus a CNI-based regimen: a systematic review and meta-analysis of randomized, controlled trials. Clin J Am Soc Nephrol 2017;12:1321-36.   DOI
8 Ahlenstiel-Grunow T, Pape L. Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation. Pediatr Nephrol 2020;35:625-31.   DOI
9 Schneidewind L, Neumann T, Drager DL, Kranz J, Hakenberg OW. Leflunomide in the treatment of BK polyomavirus associated nephropathy in kidney transplanted patients: a systematic review. Transplant Rev (Orlando) 2020;34:100565.   DOI
10 Bernhoff E, Tylden GD, Kjerpeseth LJ, Gutteberg TJ, Hirsch HH, Rinaldo CH. Leflunomide inhibition of BK virus replication in renal tubular epithelial cells. J Virol 2010;84:2150-6.   DOI
11 Dufek S, Haitel A, Muller-Sacherer T, Aufricht C. Duct Bellini carcinoma in association with BK virus nephropathy after lung transplantation. J Heart Lung Transplant 2013;32:378-9.   DOI
12 Nickeleit V, Singh HK, Randhawa P, Drachenberg CB, Bhatnagar R, Bracamonte E, et al. The Banff Working Group classification of definitive polyomavirus nephropathy: morphologic definitions and clinical correlations. J Am Soc Nephrol 2018;29:680-93.   DOI
13 Hirsch HH, Randhawa P; AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation. Am J Transplant 2013;13 Suppl 4:179-88.   DOI
14 Jung YH, Moon KC, Ha JW, Kim SJ, Ha IS, Cheong HI, et al. Leflunomide therapy for BK virus allograft nephropathy after pediatric kidney transplantation. Pediatr Transplant 2013;17:E50-4.   DOI
15 Patel SJ, Knight RJ, Kuten SA, Graviss EA, Nguyen DT, Moore LW, et al. Ciprofloxacin for BK viremia prophylaxis in kidney transplant recipients: results of a prospective, double-blind, randomized, placebo-controlled trial. Am J Transplant 2019;19:1831-7.   DOI
16 Demey B, Tinez C, Francois C, Helle F, Choukroun G, Duverlie G, et al. Risk factors for BK virus viremia and nephropathy after kidney transplantation: a systematic review. J Clin Virol 2018;109:6-12.   DOI
17 Bedi A, Miller CB, Hanson JL, Goodman S, Ambinder RF, Charache P, et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995;13:1103-9.   DOI
18 Ruderfer D, Wu M, Wang T, Srivaths PR, Krance RA, Naik S, et al. BK virus epidemiology, risk factors, and clinical outcomes: an analysis of hematopoietic stem cell transplant patients at Texas Children's Hospital. J Pediatric Infect Dis Soc 2021;10:492-501.   DOI
19 Laskin BL, Denburg MR, Furth SL, Moatz T, Altrich M, Kleiboeker S, et al. The natural history of BK polyomavirus and the host immune response after stem cell transplantation. Clin Infect Dis 2020;71:3044-54.   DOI
20 Sawinski D, Trofe-Clark J. BK virus nephropathy. Clin J Am Soc Nephrol 2018;13:1893-6.   DOI
21 Bohl DL, Brennan DC. BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol 2007;2 Suppl 1:S36-46.   DOI
22 Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971;1:1253-7.
23 Mengel M, Marwedel M, Radermacher J, Eden G, Schwarz A, Haller H, et al. Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs. Nephrol Dial Transplant 2003;18:1190-6.   DOI
24 Patel H, Rodig N, Agrawal N, Cardarelli F. Incidence and risk factors of kidney allograft loss due to BK nephropathy in the pediatric population: a retrospective analysis of the UNOS/OPTN database. Pediatr Transplant 2021;25:e13927.   DOI
25 Hurdiss DL, Frank M, Snowden JS, Macdonald A, Ranson NA. The structure of an infectious human polyomavirus and its interactions with cellular receptors. Structure 2018;26:839-47.   DOI
26 Cho MH. Monitoring BK virus infection in pediatric kidney transplant recipients. Korean J Pediatr 2019;62:414-5.   DOI
27 Lee YH, Kang HG. Pediatric kidney transplantation. Child Kidney Dis 2021;25:8-13.   DOI
28 Ducharme-Smith A, Katz BZ, Bobrowski AE, Backer CL, Pahl E. BK polyomavirus infection in pediatric heart transplant recipients: a prospective study. Pediatr Transplant 2017;21:e12830.   DOI
29 Cesaro S, Dalianis T, Hanssen Rinaldo C, Koskenvuo M, Pegoraro A, Einsele H, et al. ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients. J Antimicrob Chemother 2018;73:12-21.
30 Helle F, Brochot E, Handala L, Martin E, Castelain S, Francois C, et al. Biology of the BKPyV: an update. Viruses 2017;9:327.   DOI
31 Ginevri F, De Santis R, Comoli P, Pastorino N, Rossi C, Botti G, et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation2003;75:1266-70.   DOI
32 Schmidt T, Adam C, Hirsch HH, Janssen MW, Wolf M, Dirks J, et al. BK polyomavirus-specific cellular immune responses are age-dependent and strongly correlate with phases of virus replication. Am J Transplant 2014;14:1334-45.   DOI
33 Smith JM, McDonald RA, Finn LS, Healey PJ, Davis CL, Limaye AP. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant 2004;4:2109-17.   DOI
34 Miettinen J, Lautenschlager I, Weissbach F, Wernli M, Auvinen E, Mannonen L, et al. BK polyomavirus viremia and antibody responses of pediatric kidney transplant recipients in Finland. Pediatr Transplant 2019;23:e13324.   DOI
35 Hocker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B, et al. Epidemiology of and risk factors for BK polyomavirus replication and nephropathy in pediatric renal transplant recipients: an international CERTAIN registry study.Transplantation 2019;103:1224-33.   DOI